SARS CoV 2 News and Research

RSS

Researchers develop a new early alert model for pandemic predictions in Germany

An early alert indicator and trend forecasting model for pandemic situations in Germany.

29 Nov 2023

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Study reveals that pregnant women infected with COVID-19 had a higher risk of preterm delivery, with significant health and socioeconomic implications. However, early vaccination adopters showed protection from these effects, highlighting the critical role of vaccines in safeguarding future generations' health, especially in the U.S., where the study was conducted.

28 Nov 2023

BioEcho Life Sciences enters the US diagnostic market with an FDA-listed product

The EchoLUTION Viral RNA/DNA Kit is now available for the US diagnosis market to extract nucleic acids from viral particles with a single-step centrifugation technology, reducing processing time for in vitro diagnostic analysis.

From BioEcho Life Sciences GmbH 28 Nov 2023

Towards a world free of tuberculosis: The ADVANCE-TB COST Action

Tuberculosis (TB) is caused by Mycobacterium tuberculosis. For decades, it has been among the top 10 reasons of death globally, and the number one infectious killer.

28 Nov 2023

Associations between socioeconomic status, clinical variables, and non-COVID-19 sepsis risk

The impact of socioeconomic status and clinical variables on sepsis incidence and mortality.

28 Nov 2023

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Study compares the half-dose and full-dose Pfizer-BioNTech BNT162b2 COVID-19 booster in adults previously vaccinated with ChAdOx1, BBIBP-CorV, or Gam-COVID-Vac. It finds that the half-dose booster has fewer side effects and maintains similar immunogenicity, offering a viable option for booster vaccination strategies.

27 Nov 2023

Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

Study compares the effectiveness of bivalent and monovalent booster vaccines against COVID-19 mortality in individuals aged 65 and older. It finds that bivalent boosters show higher vaccine effectiveness against COVID-19 mortality, particularly for the Omicron variant, compared to monovalent vaccines.

27 Nov 2023

Children in daycare not significant spreaders of COVID-19, study shows

Parents who send their children to child care can breathe a little easier – research published in JAMA Network Open from experts at Michigan Medicine, the University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh shows that children in daycare were not significant spreaders of COVID-19.

27 Nov 2023

Study reveals Pfizer bivalent COVID-19 booster safer for seniors against stroke risk compared to other vaccines

The comparative hazard of ischemic stroke (IS) in recipients of booster shots.

27 Nov 2023

COVID-19 vaccines offer protection against long-term effects, study suggests

A new study in The BMJ explores how far vaccination averted PCC.

24 Nov 2023

New insights into how SARS-CoV-2 evades our immune system

This review in Cellular and Molecular Immunology delves into the innate immune response to SARS-CoV-2, exploring how the virus evades immunity and the potential role of innate immunity in long-COVID and vaccine responses, shedding light on future therapeutic strategies.

23 Nov 2023

Study quantifies high costs of managing long-COVID in non-hospitalized UK patients

A BMC Primary Care study estimates the substantial costs of long-COVID management in non-hospitalized UK patients, revealing higher expenses for patients with diagnosed long-COVID, older adults, women, obese individuals, and those with comorbidities.

23 Nov 2023

Isolation measures during pandemic drove faster, more transmissible SARS-CoV-2 variants, study reveals

A Nature Communications study finds that isolation practices during the COVID-19 pandemic influenced the evolution of SARS-CoV-2, leading to variants with earlier, higher peak viral loads but shorter infection durations, suggesting a shift towards increased transmissibility.

23 Nov 2023

SARS CoV 2 News and Research

Researchers develop a new early alert model for pandemic predictions in Germany

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

BioEcho Life Sciences enters the US diagnostic market with an FDA-listed product

Towards a world free of tuberculosis: The ADVANCE-TB COST Action

Associations between socioeconomic status, clinical variables, and non-COVID-19 sepsis risk

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Bivalent COVID-19 boosters offer stronger protection for seniors, Australian study reveals

Children in daycare not significant spreaders of COVID-19, study shows

Study reveals Pfizer bivalent COVID-19 booster safer for seniors against stroke risk compared to other vaccines

COVID-19 vaccines offer protection against long-term effects, study suggests

New insights into how SARS-CoV-2 evades our immune system

Study quantifies high costs of managing long-COVID in non-hospitalized UK patients

Isolation measures during pandemic drove faster, more transmissible SARS-CoV-2 variants, study reveals

Specific HLA alleles may be associated with SARS-CoV-2 infection

New study shows bivalent COVID-19 booster increases antibody response in lung cancer patients

Research reveals how isolation measures influence SARS-CoV-2's evolutionary trajectory

COVID-19 vaccination before first infection may reduce risk of developing long COVID

Researchers discover way to reverse brain aging caused by COVID-19

Study shows lasting effects of COVID-19 on nursing home residents

Human behavior may drive the evolution of new coronavirus strains

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News